Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cell envelope and organic biofilm matrix constitute the essential structural and protective layers of microorganisms, serving as the primary interface between the microbe and its environment (Silhavy, T. J., et al., 2010). The cell envelope, comprising the cell wall and membranes, maintains osmotic pressure and provides a scaffold for surface proteins, while the biofilm matrix—a complex mixture of extracellular polymeric substances (EPS) like polysaccharides, proteins, and eDNA—encapsulates microbial communities (Flemming, H. C., & Wingender, J., 2010). These structures are vital for survival, facilitating adherence to host tissues or medical devices and acting as a formidable barrier against host immune cells and antimicrobial agents (Hall-Stoodley, L., et al., 2004). In clinical settings, these components are major therapeutic targets for various antimicrobial classes. For instance, beta-lactam antibiotics inhibit peptidoglycan synthesis in the cell wall, while agents like DNase target the eDNA within the biofilm matrix to promote dispersal (Koo, H., et al., 2017). Disruption of these barriers is often necessary to allow other drugs to reach their intracellular targets. Understanding the composition and dynamics of these barriers is crucial for developing strategies to combat chronic infections and the rising threat of antimicrobial resistance.
Inhibition of cell wall biosynthesis (e.g., peptidoglycan cross-linking), disruption of membrane integrity, and enzymatic or chemical degradation of extracellular polymeric substances (EPS) to destabilize the biofilm architecture (Koo, H., et al., 2017; Silhavy, T. J., et al., 2010).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell envelope and organic biofilm matrix (EPS matrix).